Within the framework of the S3 Intelligent Specialization Strategy defined by the Walloon Government and its Task Force on Health Innovation, BioWin will be a partner of the Patient Numérique 2021 Symposium.
The “Patient Numérique”, a community of hospitals and leading medical IT companies, will bring together more than 300 healthcare decision-makers this year around
“DPI³ : Le Dossier Patient est-il devenu Intelligent ?” on October 28, 2021 at the WCCM in Mons.
The intelligent use of “patient data” represents a major challenge both in research and innovation and in the improvement of healthcare practices. It is one of the European priorities and is part of the initiatives underway at the federal level and in the Walloon Region. The implementation of this ambition requires the mobilization and collaboration between the actors of the existing ecosystems, including the BioWin cluster and the Digital Patient community.
During this symposium, Thibault Helleputte, CEO of DNALytics and member of the BioWin Board will chair the workshop dedicated to AI and health.
Wallonia Conference Center (WCCM)
9 Avenue Mélina Mercouri
October 28, 2021
Participation of 25 speakers in plenary sessions, workshops and debates.
You will also have access to all the online sessions on the platform and in replay on the Digital Patient YouTube channel.
This new edition of the Digital Patient symposium will be the occasion to celebrate, one year late, the tenth anniversary of the Community and will be closed by the award ceremony and a cocktail.